Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-30 @ 10:54 PM
Study NCT ID:
NCT04406857
Status:
TERMINATED
Last Update Posted:
2025-02-26
First Post:
2020-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-28
First Submit QC Date:
None
Study First Post Date:
2020-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-01
Results First Submit QC Date:
None
Results First Post Date:
2023-10-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-04
Last Update Post Date:
2025-02-26
Last Update Post Date Type:
ACTUAL